Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data

BackgroundMany countries have reported an increase in the incidence of pertussis, which has become a global public health concern.MethodsIn this study, the epidemiology of pertussis in Brazil was assessed retrospectively using surveillance data gathered from case notification forms from 2007 to 2014.ResultsFrom 2007 to 2014, 80,068 suspected cases of pertussis were reported in Brazil. Of these, 24,612 (32 %) were confirmed by various criteria. The annual distribution of confirmed cases demonstrated a significant increase in incidence rate since 2012. A seasonal pattern in which cases occur most frequently between the end of spring and midsummer has been identified. Among the confirmed cases, 34.5 % occurred in infants aged 0–2 months, 22.4 % occurred in infants aged 3–6 months, 21 % occurred in children aged 7 months to 4 years, and 8 % were reported in adults >21 years. Of the confirmed cases, 47.2 % met only clinical criteria, 15.5 % met clinical and epidemiological criteria, and 36.6 % were confirmed in a laboratory. The overall case fatality rate was 2.1 %, reaching 4.7 % among infants aged 0–2 months. The complications most commonly reported in the notification forms were pneumonia, encephalitis, dehydration, otitis, and malnutrition. Of the confirmed cases, 23.1 % occurred in subjects who received at least 3 doses of the pertussis vaccine. Within this group, there were 1098 infants aged 7 to 15 months and 2079 children aged 16 months to 4 years. In 2012, 18 states did not achieve 95 % immunization coverage, a number that dropped to 10 and 6 in 2013 and 2014, respectively.ConclusionsBrazil’s main challenges in facing pertussis resurgence will be to offer the best quality medical attention to reduce mortality, to improve the infrastructure for laboratory diagnosis and to increase vaccination coverage. Additional studies to assess the effectiveness of the current vaccination schedule and basic research on the genetics and evolution of circulating B. pertussis strains are also needed.

[1]  S. Guillot,et al.  Development of real-time PCR assay for differential detection of Bordetella bronchiseptica and Bordetella parapertussis. , 2014, Diagnostic microbiology and infectious disease.

[2]  J. Schellekens,et al.  Pertussis Sources of Infection and Routes of Transmission in the Vaccination Era , 2005, The Pediatric infectious disease journal.

[3]  N. Klein.  Licensed pertussis vaccines in the United States , 2014, Human vaccines & immunotherapeutics.

[4]  M. L. Penkal,et al.  Resurgence of pertussis at the age of vaccination: clinical, epidemiological, and molecular aspects. , 2015, Jornal de pediatria.

[5]  D. M. T. Zanetta,et al.  Vírus respiratório sincicial humano em crianças hospitalizadas por infecções agudas das vias aéreas inferiores , 2011 .

[6]  N. Andrews,et al.  The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  M. Hanlon,et al.  Acellular vaccines for preventing whooping cough in children. , 1999, The Cochrane database of systematic reviews.

[8]  P. Strebel,et al.  Underreporting of pertussis deaths in the United States: need for improved surveillance. , 1998, Pediatrics.

[9]  Linda C. Lambert.  Pertussis vaccine trials in the 1990s. , 2014, The Journal of infectious diseases.

[10]  R. Sutter,et al.  Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. , 1992, JAMA.

[11]  Seema Mattoo,et al.  Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.

[12]  Antonio E Pérez,et al.  Vaccine-related adverse events in Cuban children, 1999-2008. , 2012, MEDICC review.

[13]  F. Mooi,et al.  Antigenic Divergence between Bordetella pertussis Clinical Isolates from Moscow, Russia, and Vaccine Strains , 2007, Clinical and Vaccine Immunology.

[14]  H. Quinn,et al.  Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. , 2010, New South Wales public health bulletin.

[15]  Carol Glaser,et al.  Pertussis Epidemic — California, 2014 , 2014, MMWR. Morbidity and mortality weekly report.

[16]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[17]  E. Chiappini,et al.  Pertussis is still common in a highly vaccinated infant population , 2014, Acta paediatrica.

[18]  T. Skoff,et al.  Manual for the surveillance of vaccine-preventable diseases. Chapter 10: Pertussis , 2015 .

[19]  D. Zanetta,et al.  Human respiratory syncytial virus in children hospitalized for acute lower respiratory infection. , 2011, Jornal de pediatria.

[20]  E. Wang,et al.  Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  E. Pereira,et al.  Acellular pertussis vaccine for adolescents. , 2006, Paediatrics & child health.

[22]  H. Quinn,et al.  Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group. , 2007, Communicable diseases intelligence quarterly report.

[23]  S. Sood,et al.  Pertussis: still a cause of death, seven decades into vaccination , 2014, Current opinion in pediatrics.

[24]  K. Edwards.  Overview of Pertussis: Focus on Epidemiology, Sources of Infection, and Long Term Protection After Infant Vaccination , 2005, The Pediatric infectious disease journal.

[25]  E. Chiappini,et al.  Pertussis re-emergence in the post-vaccination era , 2013, BMC Infectious Diseases.

[26]  A. Andreu,et al.  [Microorganisms isolated in cases of pertussis-like syndrome]. , 2000, Enfermedades infecciosas y microbiologia clinica.

[27]  J. Zipprich,et al.  California pertussis epidemic, 2010. , 2012, The Journal of pediatrics.

[28]  F. Mooi,et al.  Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. , 1997, Emerging infectious diseases.

[29]  A. Leber.  Pertussis: relevant species and diagnostic update. , 2014, Clinics in laboratory medicine.

[30]  J. Hay,et al.  Economic Considerations for Pertussis Booster Vaccination in Adolescents , 2005, The Pediatric infectious disease journal.

[31]  David Alejandro Cabrera-Gaytán,et al.  Panorama epidemiológico de la tos ferina 19 años de estudio epidemiológico en el Instituto Mexicano del Seguro Social , 2015 .

[32]  Aroldo P. de Carvalho,et al.  Vacina acelular contra pertússis para adolescentes , 2006 .

[33]  J. Langley,et al.  A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection , 1999, Pediatrics.

[34]  G. Gabutti,et al.  Pertussis: A Review of Disease Epidemiology Worldwide and in Italy , 2012, International journal of environmental research and public health.